Developing new contraceptive methods for men and women
CHEMICAL SYNTHESIS FACILITY FOR CONTRACEPTIVE DEVELOPMENT
['FUNDING_OTHER'] · UNIVERSITY OF MINNESOTA · NIH-11196043
This study is exploring new birth control options for both men and women to find methods that might work better or have fewer side effects than what’s currently available.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11196043 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing a variety of contraceptive agents for both males and females. It involves synthesizing potential anti-fertility compounds in a specialized facility, ensuring they meet safety and quality standards before being tested in clinical settings. The process includes manufacturing these agents in small to large quantities, allowing for thorough evaluation of their effectiveness and safety. Patients may benefit from new contraceptive options that are more effective or have fewer side effects than current methods.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive options, particularly those who may have experienced issues with existing methods.
Not a fit: Patients who are not seeking contraceptive solutions or those who have contraindications to hormonal treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative contraceptive methods that improve reproductive health options for individuals.
How similar studies have performed: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new methods.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GURVICH, VADIM — UNIVERSITY OF MINNESOTA
- Study coordinator: GURVICH, VADIM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.